Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114
Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases
Lian Wang, Yanghui Zhu, Lu Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 41
Targeting the undruggables—the power of protein degraders
Chao Zhang, Yongbo Liu, Guangchen Li, et al.
Science Bulletin (2024) Vol. 69, Iss. 11, pp. 1776-1797
Open Access | Times Cited: 18
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
De novo design of peptide binders to conformationally diverse targets with contrastive language modeling
Suhaas Bhat, Kalyan Palepu, Lauren Hong, et al.
Science Advances (2025) Vol. 11, Iss. 4
Closed Access | Times Cited: 5
Journey of PROTAC: From Bench to Clinical Trial and Beyond
Kyli Berkley, Julian Zalejski, Nidhi Sharma, et al.
Biochemistry (2025)
Closed Access | Times Cited: 3
Modulation of Nrf2 expression by targeting i-motif DNA
Emily F. Warner, Dilek Guneri, Maria A. O’Connell, et al.
Communications Chemistry (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Allosteric drugs: New principles and design approaches
Wei-Ven Tee, Igor N. Berezovsky
Current Opinion in Structural Biology (2024) Vol. 84, pp. 102758-102758
Closed Access | Times Cited: 13
A promising future of metal‐N‐heterocyclic carbene complexes in medicinal chemistry: The emerging bioorganometallic antitumor agents
Qian Zhao, Bo Han, Cheng Peng, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2194-2235
Closed Access | Times Cited: 12
Evolution of Pyrrolysyl-tRNA Synthetase: From Methanogenesis to Genetic Code Expansion
Nikolaj G. Koch, Nediljko Budiša
Chemical Reviews (2024) Vol. 124, Iss. 16, pp. 9580-9608
Open Access | Times Cited: 12
Dietary flavonoid actions on senescence, aging, and applications for health
Bruce A. Watkins, Alyson E. Mitchell, Andrew C. Shin, et al.
The Journal of Nutritional Biochemistry (2025), pp. 109862-109862
Closed Access | Times Cited: 1
The evolution and application of RNA-focused small molecule libraries
Amirhossein Taghavi, Noah A. Springer, Patrick R. A. Zanon, et al.
RSC Chemical Biology (2025)
Open Access | Times Cited: 1
RNAi technology development for weed control: all smoke and no fire?
Silvia Panozzo, Andrea Milani, Sara Bordignon, et al.
Pest Management Science (2025)
Open Access | Times Cited: 1
Revisiting the Plasmodium falciparum druggable genome using predicted structures and data mining
Karla P. Godinez‐Macias, Daisy Chen, John Wallis, et al.
npj Drug Discovery. (2025) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Nanoparticles insert a three dimensional cavity structure of proteins for function inhibition: The Case of CeO2 and SARS-CoV-2
Guofang Zhang, Xiaofeng Wang, Guocheng Wang, et al.
Nano Today (2024) Vol. 55, pp. 102183-102183
Closed Access | Times Cited: 7
The value of protein allostery in rational anticancer drug design: an update
Ruth Nussinov, Hyunbum Jang
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1071-1085
Open Access | Times Cited: 7
Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation
Weiyuan Wang, Melanie Cristina Lopez McDonald, Rajashree Hariprasad, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1387-1387
Open Access | Times Cited: 6
Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders
Runxuan Chu, Yi Wang, Jianglong Kong, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 20, pp. 4759-4784
Closed Access | Times Cited: 6
The potential of Sonneratia caseolaris mangrove leaves extract as a bioactive food ingredient using various water extract
Hartati Kartikaningsih, Nur Fitriana, Ike Listya Anggraeni, et al.
F1000Research (2025) Vol. 13, pp. 249-249
Open Access
Natural products targeting RAS by multiple mechanisms and its therapeutic potential in cancer: An update since 2020
Yanqing Liu, Jie Chen, Xiang Li, et al.
Pharmacological Research (2025) Vol. 212, pp. 107577-107577
Open Access
Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets
Soyoung Jeon, Yong‐Duck Chung, Jae‐Sung Lim, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Computational advances in discovering cryptic pockets for drug discovery
Martijn P. Bemelmans, Zoe Cournia, Kelly L. Damm‐Ganamet, et al.
Current Opinion in Structural Biology (2025) Vol. 90, pp. 102975-102975
Open Access
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access
Current Strategies and Future Dimensions in the Development of KRAS Inhibitors for Targeted Anticancer Therapy
Laura D'Alessio‐Sands, Joshua Gaynier, Victoria Michel‐Milian, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
Lisha Ou, Mekedlawit Setegne, Jeandele Elliot, et al.
Chemical Reviews (2025)
Closed Access
Page 1 - Next Page

Scroll to top